{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:44:47Z","timestamp":1790948687840,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.ejpb.2020.10.010","type":"journal-article","created":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T21:33:24Z","timestamp":1603488804000},"page":"200-210","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"special_numbering":"C","title":["Spray-dried multidrug particles for pulmonary co-delivery of antibiotics with N-acetylcysteine and curcumin-loaded PLGA-nanoparticles"],"prefix":"10.1016","volume":"157","author":[{"given":"Nashrawan","family":"Lababidi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Victor","family":"Montefusco-Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiane","family":"de Souza Carvalho-Wodarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus-Michael","family":"Lehr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2020.10.010_b0005","first-page":"21","article-title":"Towards the identification of the common features of bacterial biofilm development","volume":"9","author":"Lasa","year":"2006","journal-title":"Int. Microbiol."},{"key":"10.1016\/j.ejpb.2020.10.010_b0010","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/1851242","article-title":"Recent nanotechnology approaches for prevention and treatment of biofilm-associated infections on medical devices","volume":"2016","author":"Ramasamy","year":"2016","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.ejpb.2020.10.010_b0015","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s002849900084","article-title":"Inhibition of macrophage phagocytosis by Pseudomonas aeruginosa rhamnolipids in vitro and in vivo","volume":"33","author":"McClure","year":"1996","journal-title":"Curr. Microbiol."},{"key":"10.1016\/j.ejpb.2020.10.010_b0020","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1258\/0022215054516313","article-title":"Pseudomonas aeruginosa lectins I and II and their interaction with human airway cilia","volume":"119","author":"Mewe","year":"2005","journal-title":"J. Laryngol. Otol."},{"key":"10.1016\/j.ejpb.2020.10.010_b0025","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/bmb\/61.1.81","article-title":"Persistent and aggressive bacteria in the lungs of cystic fibrosis children","volume":"61","author":"Hart","year":"2002","journal-title":"Br. Med. Bull."},{"key":"10.1016\/j.ejpb.2020.10.010_b0030","first-page":"249","article-title":"Infections with Pseudomonas aeruginosa in patients with cystic fibrosis","author":"T\u00fcmmler","year":"1997","journal-title":"Behring Inst. Mitt."},{"key":"10.1016\/j.ejpb.2020.10.010_b0035","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1080\/17476348.2016.1177460","article-title":"Pseudomonas aeruginosa infection in cystic fibrosis: pathophysiological mechanisms and therapeutic approaches","volume":"10","author":"Lund-Palau","year":"2016","journal-title":"Expert Rev Respir Med"},{"key":"10.1016\/j.ejpb.2020.10.010_b0040","doi-asserted-by":"crossref","DOI":"10.1093\/eurpub\/cky032","article-title":"Deciding on cystic fibrosis carrier screening: three citizens\u2019 juries and an online survey","author":"Mosconi","year":"2018","journal-title":"Eur. J. Pub. Health"},{"key":"10.1016\/j.ejpb.2020.10.010_b0045","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1016\/S1569-1993(11)60011-8","article-title":"Chronic pseudomonas aeruginosa infection definition: EuroCareCF working group report","volume":"10","author":"Pressler","year":"2011","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.ejpb.2020.10.010_b0050","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/1469-0691.12651","article-title":"Antimicrobial susceptibility testing in biofilm-growing bacteria","volume":"20","author":"Macia","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.ejpb.2020.10.010_b0055","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jconrel.2014.03.055","article-title":"Lipid and polymer nanoparticles for drug delivery to bacterial biofilms","volume":"190","author":"Forier","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2020.10.010_b0060","doi-asserted-by":"crossref","first-page":"18355","DOI":"10.1073\/pnas.1214066109","article-title":"Optical tweezers reveal relationship between microstructure and nanoparticle penetration of pulmonary mucus","volume":"109","author":"Kirch","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejpb.2020.10.010_b0065","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.tcb.2011.06.002","article-title":"Biological hydrogels as selective diffusion barriers","volume":"21","author":"Lieleg","year":"2011","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.ejpb.2020.10.010_b0070","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1166\/jnn.2014.9015","article-title":"Mucus as barrier for drug delivery by nanoparticles","volume":"14","author":"Fr\u00f6hlich","year":"2014","journal-title":"J. Nanosci. Nanotechnol."},{"key":"10.1016\/j.ejpb.2020.10.010_b0075","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.addr.2008.09.008","article-title":"Barrier properties of mucus","volume":"61","author":"Cone","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2020.10.010_b0080","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2174\/2210303104666140222002101","article-title":"Inhalable antibiotic nanoformulations for the treatment of Pseudomonas Aeruginosa infection in cystic fibrosis - a review","volume":"4","author":"G\u00fcnday Tureli","year":"2014","journal-title":"Drug Delivery Lett."},{"key":"10.1016\/j.ejpb.2020.10.010_b0085","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1021\/js950381s","article-title":"Drug diffusion through cystic fibrotic mucus: Steady-state permeation, rheologic properties, and glycoprotein morphology","volume":"85","author":"Bhat","year":"1996","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2020.10.010_b0090","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1111\/j.2042-7158.2012.01486.x","article-title":"Engineered PLGA nano-and micro-carriers for pulmonary delivery: challenges and promises","volume":"64","author":"Ungaro","year":"2012","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejpb.2020.10.010_b0095","article-title":"Respiratory drug delivery: Essential theory and practice","author":"Newman","year":"2009","journal-title":"Respiratory Drug Delivery Online"},{"key":"10.1016\/j.ejpb.2020.10.010_b0100","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1046\/j.1365-2125.2003.01892.x","article-title":"Pulmonary drug delivery. Part I: physiological factors affecting therapeutic effectiveness of aerosolized medications","volume":"56","author":"Labiris","year":"2003","journal-title":"Brit. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejpb.2020.10.010_b0105","doi-asserted-by":"crossref","unstructured":"A. Henning, S. Hein, M. Schneider, M. Bur, C.-M. Lehr, Pulmonary drug delivery: medicines for inhalation, in: Drug Delivery, Springer, 2010, pp. 171-192.","DOI":"10.1007\/978-3-642-00477-3_6"},{"key":"10.1016\/j.ejpb.2020.10.010_b0110","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1513\/pats.200409-046TA","article-title":"Deposition of inhaled particles in the human respiratory tract and consequences for regional targeting in respiratory drug delivery","volume":"1","author":"Heyder","year":"2004","journal-title":"Proc. Am. Thoracic Soc."},{"key":"10.1016\/j.ejpb.2020.10.010_b0115","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ejps.2017.04.003","article-title":"The influence of mannitol on morphology and disintegration of spray-dried nano-embedded microparticles","volume":"104","author":"Torge","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2020.10.010_b0120","doi-asserted-by":"crossref","first-page":"12001","DOI":"10.1073\/pnas.182233999","article-title":"Trojan particles: large porous carriers of nanoparticles for drug delivery","volume":"99","author":"Tsapis","year":"2002","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejpb.2020.10.010_b0125","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.addr.2007.08.038","article-title":"Controlled drug delivery in tissue engineering","volume":"60","author":"Biondi","year":"2008","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.ejpb.2020.10.010_b0130","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.powtec.2010.06.003","article-title":"Aqueous re-dispersibility of spray-dried antibiotic-loaded polycaprolactone nanoparticle aggregates for inhaled anti-biofilm therapy","volume":"203","author":"Kho","year":"2010","journal-title":"Powder Technol."},{"key":"10.1016\/j.ejpb.2020.10.010_b0135","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ijpharm.2003.09.041","article-title":"Formulation and characterization of spray-dried powders containing nanoparticles for aerosol delivery to the lung","volume":"269","author":"Sham","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2020.10.010_b0140","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ejps.2005.04.009","article-title":"Microencapsulated chitosan nanoparticles for lung protein delivery","volume":"25","author":"Grenha","year":"2005","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2020.10.010_b0145","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jconrel.2019.10.038","article-title":"Spray-drying of inhalable, multifunctional formulations for the treatment of biofilms formed in cystic fibrosis","volume":"314","author":"Lababidi","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2020.10.010_b0150","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1164\/ajrccm.152.6.8520783","article-title":"Inflammatory cytokines in cystic fibrosis lungs","volume":"152","author":"Bonfield","year":"1995","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejpb.2020.10.010_b0155","first-page":"1075","article-title":"Early pulmonary inflammation in infants with cystic fibrosis","volume":"151","author":"Khan","year":"1995","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejpb.2020.10.010_b0160","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1021\/mp700113r","article-title":"Bioavailability of curcumin: problems and promises","volume":"4","author":"Anand","year":"2007","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2020.10.010_b0165","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1093\/carcin\/bgl241","article-title":"Chemopreventive anti-inflammatory activities of curcumin and other phytochemicals mediated by MAP kinase phosphatase-5 in prostate cells","volume":"28","author":"Nonn","year":"2006","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ejpb.2020.10.010_b0170","doi-asserted-by":"crossref","first-page":"5767","DOI":"10.4049\/jimmunol.165.10.5767","article-title":"Gene expressions of Toll-like receptor 2, but not Toll-like receptor 4, is induced by LPS and inflammatory cytokines in mouse macrophages","volume":"165","author":"Matsuguchi","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejpb.2020.10.010_b0175","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.bcp.2006.03.022","article-title":"Inhibition of homodimerization of Toll-like receptor 4 by curcumin","volume":"72","author":"Youn","year":"2006","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejpb.2020.10.010_b0180","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1189\/jlb.1206727","article-title":"MD-2 as the target of curcumin in the inhibition of response to LPS","volume":"82","author":"Gradi\u0161ar","year":"2007","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.ejpb.2020.10.010_b0185","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0169-409X(02)00228-4","article-title":"Biodegradable nanoparticles for drug and gene delivery to cells and tissue","volume":"55","author":"Panyam","year":"2003","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2020.10.010_b0190","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.3762\/bjnano.10.220","article-title":"Microfluidics as tool to prepare size-tunable PLGA nanoparticles with high curcumin encapsulation for efficient mucus penetration","volume":"10","author":"Lababidi","year":"2019","journal-title":"Beilstein J. Nanotechnol."},{"key":"10.1016\/j.ejpb.2020.10.010_b0195","doi-asserted-by":"crossref","unstructured":"N. Nafee, M. Schneider, Towards a versatile technique for tracking nanoparticle-mucus interaction: A step on the road, in: SPIE Photonics West - BiOS, SPIE, San Francisco, 2014.","DOI":"10.1117\/12.2043047"},{"key":"10.1016\/j.ejpb.2020.10.010_b0200","first-page":"211","article-title":"Co-culture of human alveolar epithelial (hAELVi) and macrophage (THP-1) cell lines","volume":"35","author":"Kletting","year":"2018","journal-title":"ALTEX-Alternatives Animal Experimentation"},{"key":"10.1016\/j.ejpb.2020.10.010_b0205","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jconrel.2014.06.055","article-title":"Antibiotic-free nanotherapeutics: Ultra-small, mucus-penetrating solid lipid nanoparticles enhance the pulmonary delivery and anti-virulence efficacy of novel quorum sensing inhibitors","volume":"192","author":"Nafee","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2020.10.010_b0210","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1002\/ange.201006849","article-title":"Biodegradable nanoparticles composed entirely of safe materials that rapidly penetrate human mucus","volume":"123","author":"Yang","year":"2011","journal-title":"Angew. Chem."},{"key":"10.1016\/j.ejpb.2020.10.010_b0215","unstructured":"R. Edward DeSimone, PhD, FAPhA, Cystic Fibrosis: Update on Treatment Guidelines and New Recommendations, https:\/\/www.uspharmacist.com\/article\/cystic-fibrosis-update-on-treatment-guidelines-and-new-recommendations, (2018)."},{"key":"10.1016\/j.ejpb.2020.10.010_b0220","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejps.2019.02.025","article-title":"Development of inhalable curcumin loaded Nano-in-Microparticles for bronchoscopic photodynamic therapy","volume":"132","author":"Baghdan","year":"2019","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2020.10.010_b0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2016.11.036","article-title":"Does size really matter?: Relationship of particle size to lung deposition and exhaled fraction","volume":"139","author":"Jabbal","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ejpb.2020.10.010_b0230","doi-asserted-by":"crossref","first-page":"8080","DOI":"10.1039\/C6NR09736G","article-title":"The particle in the spider's web: transport through biological hydrogels","volume":"9","author":"Witten","year":"2017","journal-title":"Nanoscale"},{"key":"10.1016\/j.ejpb.2020.10.010_b0235","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.pupt.2005.12.007","article-title":"Antioxidant and anti-inflammatory efficacy of NAC in the treatment of COPD: discordant in vitro and in vivo dose-effects: a review","volume":"20","author":"Sadowska","year":"2007","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.ejpb.2020.10.010_b0240","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1128\/jcm.5.1.58-61.1977","article-title":"Effect of N-acetylcysteine on antibiotic activity and bacterial growth in vitro","volume":"5","author":"Parry","year":"1977","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.ejpb.2020.10.010_b0245","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00306-13","article-title":"Ciprofloxacin is actively transported across bronchial lung epithelial using a Calu-3 air-interface cell model","author":"Ong","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejpb.2020.10.010_b0250","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/08923973.2018.1474921","article-title":"Curcumin reduces the expression of interleukin 1beta and the production of interleukin 6 and tumor necrosis factor alpha by M1 macrophages from patients with Behcet's disease","volume":"40","author":"Palizgir","year":"2018","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"10.1016\/j.ejpb.2020.10.010_b0255","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3109\/01902148.2014.934411","article-title":"N-acetylcysteine and azithromycin affect the innate immune response in cystic fibrosis bronchial epithelial cells in vitro","volume":"41","author":"Hussain","year":"2015","journal-title":"Exp. Lung Res."},{"key":"10.1016\/j.ejpb.2020.10.010_b0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2011.10.027","article-title":"Azithromycin fails to reduce inflammation in cystic fibrosis airway epithelial cells","volume":"674","author":"Saint-Criq","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejpb.2020.10.010_b0265","doi-asserted-by":"crossref","DOI":"10.3791\/2186-v","article-title":"Co-culture models of Pseudomonas aeruginosa biofilms grown on live human airway cells","author":"Moreau-Marquis","year":"2010","journal-title":"J Vis Exp"},{"key":"10.1016\/j.ejpb.2020.10.010_b0270","unstructured":"J. Juntke, X. Murgia, N. G\u00fcnday Tureli, A.E. T\u00fcreli, C. Carvalho-Wodarz, M. Schneider, N. Schneider-Daum, C.-M. Lehr, Novel-co-culture model of human airway cells and P. aeruginosa biofilms, Altex, (in preparation)."},{"key":"10.1016\/j.ejpb.2020.10.010_b0275","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/00365540050164263","article-title":"TNF-a and IL-8 in consecutive sputum samples from cystic fibrosis patients during antibiotic treatment","volume":"32","author":"Karpati","year":"2000","journal-title":"Scand. J. Infect. Dis."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641120303118?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641120303118?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:41:34Z","timestamp":1760546494000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641120303118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":55,"alternative-id":["S0939641120303118"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2020.10.010","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Spray-dried multidrug particles for pulmonary co-delivery of antibiotics with N-acetylcysteine and curcumin-loaded PLGA-nanoparticles","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2020.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}